Holen Sie sich die Stockscreener-App
162.72
0.89%
-1.6786
Schlusskurs vom Vortag:
$164.40
Offen:
$164.11
24-Stunden-Volumen:
709.64K
Relative Volume:
0.29
Marktkapitalisierung:
$34.36B
Einnahmen:
$398.11M
Nettoeinkommen (Verlust:
$-1.03B
KGV:
-28.53
EPS:
-5.7032
Netto-Cashflow:
$-868.57M
1W Leistung:
+3.68%
1M Leistung:
+11.66%
6M Leistung:
+151.41%
1J Leistung:
+127.25%
1-Tages-Spanne:
$161.31
$164.23
1-Wochen-Bereich:
$156.87
$164.58
52-Wochen-Spanne:
$60.40
$164.58
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
162.55 | 34.75B | 398.11M | -1.03B | -868.57M | -5.7032 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.88 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.90 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.99 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
797.24 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
322.57 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
How buyback programs support Insmed Incorporated (IM8N) stockMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com
Insmed Incorporated stock prediction for this weekQuarterly Earnings Report & Free Fast Gain Swing Trade Alerts - newser.com
What does recent volatility data suggest for Insmed Incorporated2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
Reversal indicators forming on Insmed Incorporated stockWeekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
Insmed stock hits 52-week high at 164.04 USD - Investing.com India
Insmed stock hits 52-week high at 164.04 USD By Investing.com - Investing.com South Africa
How to interpret RSI for Insmed Incorporated stock2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
What moving averages say about Insmed Incorporated2025 Price Targets & Smart Allocation Stock Reports - newser.com
Is Insmed Incorporated trending in predictive chart modelsWeekly Trend Summary & Daily Price Action Insights - newser.com
How to build a custom watchlist for Insmed IncorporatedTrend Reversal & Safe Capital Allocation Plans - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Insmed (NASDAQ:INSM) - MarketBeat
Insmed, Inc. Hits New 52-Week High of $162.44, Up 171% Year-Over-Year - Markets Mojo
Pulmonary Arterial Hypertension Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma - The Globe and Mail
This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs - MSN
RBC Lifts Price Target on Insmed to $139 From $138, Keeps Outperform Rating - MarketScreener
Insmed (NASDAQ:INSM) Sets New 12-Month HighShould You Buy? - MarketBeat
This ‘Strong Buy’ Stock Is Trading At New 20-Year Highs - Barchart.com
Insmed, Inc. Hits New 52-Week High of $158.19, Up 162% - Markets Mojo
Is Insmed Incorporated a good long term investmentMorning Star Patterns & Free Popular Stock Picks Selection - earlytimes.in
111 Capital Makes New Investment in Insmed, Inc. $INSM - MarketBeat
How Insmed Incorporated (IM8N) stock performs during market turbulenceJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
Chung Wu Investment Group LLC Takes $173,000 Position in Insmed, Inc. $INSM - MarketBeat
Can Insmed Incorporated stock maintain operating marginsQuarterly Investment Review & Low Volatility Stock Suggestions - newser.com
Is Insmed Incorporated (IM8N) stock bottoming after sell offPortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
How Analysts Are Rethinking Insmed After Brinsupri’s Approval and New Revenue Projections - Yahoo Finance
A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $102 to $124 - 富途牛牛
Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Goldman Sachs Raises Insmed (INSM) Price Target to $196 | INSM S - GuruFocus
Insmed (NASDAQ:INSM) Price Target Raised to $196.00 at The Goldman Sachs Group - MarketBeat
Real time breakdown of Insmed Incorporated stock performanceEarnings Recap Report & Fast Gaining Stock Reports - newser.com
Goldman Sachs Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $196 - 富途牛牛
GAMMA Investing LLC Cuts Stock Holdings in Insmed, Inc. $INSM - Defense World
Insmed (NASDAQ:INSM) Given New $193.00 Price Target at TD Cowen - Defense World
Insmed (NASDAQ:INSM) Reaches New 12-Month High on Analyst Upgrade - Defense World
Insmed stock hits 52-week high at 149.2 USD By Investing.com - Investing.com Nigeria
Insmed (NASDAQ:INSM) Sets New 1-Year High After Analyst Upgrade - MarketBeat
Insmed stock hits 52-week high at 149.2 USD - Investing.com
TD Cowen Raises Price Target for Insmed (INSM) to $193 | INSM St - GuruFocus
TD Cowen Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price - MarketBeat
Ohio Retirement Fund Invests in Insmed Incorporated (INSM) - Yahoo Finance
Insmed, Inc. Hits Day High with Strong 5.09% Intraday Surge - Markets Mojo
Evercore Initiates Insmed(INSM.US) With Buy Rating, Announces Target Price $180 - 富途牛牛
Insmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A Optionality - Seeking Alpha
Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% - Yahoo
S&P 500 Futures Decline in Premarket Trading; Firefly Aerospace, Insmed Lag - Barron's
Public Employees Retirement System of Ohio Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Goldman's 48 potential M&A candidates (INSM:NASDAQ) - Seeking Alpha
Insmed Incorporated Stock Analysis and ForecastInsider Trading Compliance & Access Free Tools and Start Investing - Early Times
Insmed Incorporated stock trendline breakdown2025 Big Picture & Safe Entry Zone Identification - newser.com
RBC Capital Remains Bullish on Insmed Incorporated (INSM) - Yahoo Finance
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Insmed Inc-Aktie (INSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Sep 12 '25 |
Sale |
145.45 |
76,520 |
11,129,927 |
36,461 |
| SHAROKY MELVIN MD | Director |
Sep 12 '25 |
Sale |
145.39 |
10,000 |
1,453,900 |
262,675 |
4.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):